Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Enterprise Value: 2010-2025

Historic Enterprise Value for ProPhase Labs (PRPH) over the last 16 years, with Sep 2025 value amounting to $18.6 million.

  • ProPhase Labs' Enterprise Value fell 58.71% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 51.23%. This contributed to the annual value of $17.4 million for FY2024, which is 77.36% down from last year.
  • Per ProPhase Labs' latest filing, its Enterprise Value stood at $18.6 million for Q3 2025, which was up 15.72% from $16.1 million recorded in Q2 2025.
  • ProPhase Labs' 5-year Enterprise Value high stood at $165.3 million for Q2 2022, and its period low was $9.6 million during Q1 2025.
  • Over the past 3 years, ProPhase Labs' median Enterprise Value value was $70.3 million (recorded in 2023), while the average stood at $61.6 million.
  • Per our database at Business Quant, ProPhase Labs' Enterprise Value surged by 438.53% in 2021 and then slumped by 91.68% in 2025.
  • Over the past 5 years, ProPhase Labs' Enterprise Value (Quarterly) stood at $94.0 million in 2021, then spiked by 48.16% to $139.3 million in 2022, then crashed by 44.85% to $76.8 million in 2023, then crashed by 77.36% to $17.4 million in 2024, then plummeted by 58.71% to $18.6 million in 2025.
  • Its Enterprise Value stands at $18.6 million for Q3 2025, versus $16.1 million for Q2 2025 and $9.6 million for Q1 2025.